DoBrain Raises KRW 21 Billion to Enhance Cognitive Development Services

South Korean digital healthcare startup DoBrain has secured a KRW 21 billion Series B investment. InterVest, a new investor, led the round with a KRW 15 billion contribution, joined by a domestic insurance company and existing investor KB Investment.
DoBrain is pioneering a digital healthcare model that overcomes location and cost limitations. They offer a comprehensive range of services, from personalized cognitive training programs through their DoBrain2 app for children’s cognitive development to “D-kit,” designated as an innovative medical device in December 2022. They also provide online coaching classes for caregivers known as “WeVillee Homes,” alongside WeVillee Kids, an offline treatment center recognized by the QABA as an ABAT-certified institution.

DoBrain is preparing for FDA certification to register its cognitive digital therapeutic (DTx) solutions in the United States.
With this new investment, DoBrain aims to focus on developing services and products that address the challenges faced by children with varying developmental needs and their families. DoBrain’s mission is to make the world a place where more children can receive the support they need for their development, similar to a hospital on the moon.
DoBrain’s app has been downloaded over 600,000 times worldwide, with a retention rate of over 90%. It is actively used in various countries, including Cambodia, India, the United States, and Dubai.
관련 기사
- Korean Health Tech Mezoo Secures KRW 18B in Series B Funding for HiCardi
- Medipixel Secures KRW 17 Billion in Series B Funding for AI Cardiovascular Solution
- 스위트바이오, 롯데벤처스재팬서 2억엔 시리즈B 브릿지 투자 유치
- Medicos Biotech Secures $10 Million Investment and Forms Joint Venture with Rokline
- MedInTech Secures 20 billion KRW Series B Investment for Innovative Medical Endoscope


답글 남기기
댓글을 달기 위해서는 로그인해야합니다.